PAH medication

DRUG2 trials

Sponsors

Bayer, Janssen-Cilag S.p.A.

Conditions

Pulmonary Arterial Hypertension

Unknown Phase

Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs

CompletedNCT03863990

BayerPulmonary Arterial Hypertension

Start: 2019-07-15End: 2020-05-11Updated: 2021-05-04

A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

CompletedNCT04567602

Janssen-Cilag S.p.A.Pulmonary Arterial Hypertension

Start: 2020-10-06End: 2024-03-05Updated: 2025-06-25

Related Papers

Understanding the burden of pulmonary arterial hypertension among patients and caregivers through narrative medicine: data from Italian multicentre observational INSPECTIO study.

2026-04-09